France-based chemicals company Arkema has sold its stake in US-based medical technologies group Oxford Performance Materials (OPM).

France-based chemicals company Arkema has sold its stake in US-based medical technologies group Oxford Performance Materials (OPM).

The French chemical producer bought a stake in the company in 2009 from venture capital funds in which Netherlands-based DSM was a limited partner, according to news provider Plasteurope.com.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?